Cancer Pathogenesis and Therapy Oncology
From “undruggable” to tractable: Therapeutic advances targeting Kristen rat sarcoma viral homolog glycine to cysteine mutation at codon 12 (KRAS G12C)-mutant cancers and emerging resistance mechanisms
The publisher did not provide an abstract — full text is available via the link below.